{
    "organizations": [],
    "uuid": "5261f14debd9b369941e4bb266bd80618ddb8d34",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jilin-province-huinan-changlong-bi/brief-jilin-province-huinan-changlong-bio-pharmacy-co-says-fy-revenue-rmb645-3-mln-idUSFWN1RB0M1",
    "ord_in_thread": 0,
    "title": "Jilin Province Huinan Changlong Bio-Pharmacy Co Says FY Revenue RMB645.3 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Jilin Province Huinan Changlong Bio-Pharmacy Co Ltd:\n* FY REVENUE RMB645.3 MILLION VERSUS RMB654.1 MILLION * FY ‚ÄçPROFIT ATTRIBUTABLE RMB144.4 MILLION VERSUS RMB142.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T21:37:00.000+03:00",
    "crawled": "2018-03-30T13:30:40.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "jilin",
        "province",
        "huinan",
        "changlong",
        "co",
        "ltd",
        "fy",
        "revenue",
        "million",
        "versus",
        "million",
        "fy",
        "attributable",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}